Federal Register / Vol. 75, No. 45 / Tuesday, March 9, 2010 / Notices 10789 

days after the deadline for submission of 

case briefs, pursuant to 19 CFR 

351.309(d)(1). A list of authorities relied 

upon, a table of contents, and an 

executive summary of issues should 

accompany any briefs submitted to the 

Department. Executive summaries 

should be limited to five pages total, 

including footnotes. See 19 CFR 

351.309(c)(2) and (d)(2). 

Section 774 of the Act provides that 

the Department will hold a public 

hearing to afford interested parties an 

opportunity to comment on arguments 

raised in case or rebuttal briefs, 

provided that such a hearing is 

requested by an interested party. See 

also 19 CFR 351.310(c). If a request for 

a hearing is made in this investigation, 

the hearing will be held two days after 

the deadline for submission of the 

rebuttal briefs, pursuant to 19 CFR 

351.310(d), at the U.S. Department of 

Commerce, 14th Street and Constitution 

Avenue, N.W., Washington, D.C. 20230. 

Parties should confirm by telephone the 

time, date, and place of the hearing 48 

hours before the scheduled time. 

Interested parties who wish to request 

a hearing, or to participate if one is 

requested, must submit a written 

request to the Assistant Secretary for 

Import Administration, U.S. Department 

of Commerce, Room 1870, 14th Street 

and Constitution Avenue, N.W., 

Washington, DC 20230, within 30 days 

of the publication of this notice, 

pursuant to 19 CFR 351.310(c). Requests 

should contain: (1) the party’s name, 

address, and telephone; (2) the number 

of participants; and (3) a list of the 

issues to be discussed. Oral 

presentations will be limited to issues 

raised in the briefs. See id. 

This determination is published 

pursuant to sections 703(f) and 777(i) of 

the Act. 

Dated: March 1, 2010. 

Carole A. Showers, 

Acting Deputy Assistant Secretary for Import 

Administration. 

[FR Doc. 2010–5007 Filed 3–8–10; 8:45 am] 

BILLING CODE 3510–DS–S 

COMMITTEE FOR PURCHASE FROM 

PEOPLE WHO ARE BLIND OR 

SEVERELY DISABLED 

Appointments to Performance Review 

Board for Senior Executive Service 

AGENCY: Committee for Purchase From 

People Who Are Blind or Severely 

Disabled. 

ACTION: Appointment of Performance 

Review Board for Senior Executive 

Service. 

SUMMARY: The Committee For Purchase 

from People Who Are Blind Or Severely 

Disabled (Committee) has announced 

the following appointments to the 

Committee Performance Review Board. 

The following individuals are 

appointed as members of the Committee 

Performance Review Board responsible 

for making recommendations to the 

appointing and awarding authorities on 

performance appraisal ratings and 

performance awards for Senior 

Executive Service employees: 

Perry E. Anthony, Ph.D., Deputy 

Commissioner, Rehabilitation 

Services Administration, Department 

of Education. 

Abram Claude, Jr., Private Citizen 

Paul M. Laird, Assistant Director, 

Industries, Education and Vocational 

Training and Chief Operating Officer/ 

FPI, Department of Justice. 

All appointments are made pursuant 

to Section 4314 of Chapter 43 of Title 

5 of the United States Code. 

DATES: Effective Date: March 10, 2010. 

FOR FURTHER INFORMATION CONTACT: 

Patricia Briscoe, Telephone: (703) 603– 

7740, Fax: (703) 603–0655, or e-mail 

CMTEFedReg@abilityone.gov. 

Patricia Briscoe, 

Deputy Director, Business Operations. 

[FR Doc. 2010–4919 Filed 3–8–10; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF DEFENSE 

Office of the Secretary 

Meeting of the Uniform Formulary 

Beneficiary Advisory Panel 

AGENCY: Assistant Secretary of Defense 

(Health Affairs), DoD. 

ACTION: Notice of meeting. 

SUMMARY: Under the provisions of the 

Federal Advisory Committee Act of 

1972 (5 U.S.C., Appendix) and the 

Government in the Sunshine Act of 

1976 (5 U.S.C. 552b) the Department of 

Defense announces that the Uniform 

Formulary Beneficiary Advisory Panel 

(hereafter referred to as the Panel) will 

meet on March 25, 2010. 

DATES: The meeting will be held on 

March 25, 2010, from 8 a.m. to 5 p.m 

and will be open to the public from 9 

a.m. to 5 p.m. 

ADDRESSES: The meeting will be held at 

the Naval Heritage Center Theater, 701 

Pennsylvania Avenue, NW., 

Washington, DC 20004. 

FOR FURTHER INFORMATION CONTACT: 

Lieutenant Colonel Thomas Bacon, 

Designated Federal Officer, Uniform 

Formulary Beneficiary Advisory Panel, 

5111 Leesburg Pike, Skyline 5, Suite 

810, Falls Church, VA 22041–3206, 

Telephone: (703) 681–2890 Fax: (703) 

681–1940, E-mail: 

Baprequests@tma.osd.mil. 

SUPPLEMENTARY INFORMATION: 

Purpose of Meeting 

The Panel will review and comment 

on recommendations made to the 

Director, TRICARE Management 

Activity, by the Pharmacy and 

Therapeutics Committee regarding the 

Uniform Formulary. 

Meeting Agenda 

Sign-In; Welcome and Opening 

Remarks; Public Citizen Comments; 

Scheduled Therapeutic Class Reviews— 

Basal Insulins; Antihemophilic Factors; 

Designated Newly Approved Drugs and 

Drugs recommended for non-formulary 

placement due to non-compliance with 

Fiscal Year 2008, National Defense 

Authorization Act, Section 703; Panel 

Discussions and Vote, and comments 

following each therapeutic class review. 

Meeting Accessibility 

Pursuant to 5 U.S.C. 552b, as 

amended, and 41 CFR 102–3.140 

through 102–3.165, and the availability 

of space this meeting is open to the 

public from 9 a.m. to 5 p.m. Seating is 

limited and will be provided only to the 

first 220 people signing in. All persons 

must sign in legibly. 

Administrative Work Meeting 

Prior to the public meeting the Panel 

will conduct an Administrative Work 

Meeting from 8 a.m. to 9 a.m. to discuss 

administrative matters of the Panel. The 

Administrative Work Meeting will be 

held at the Naval Heritage Center, 701 

Pennsylvania Avenue, NW., 

Washington, DC, 20004. Pursuant to 41 

CFR 102–3.160, the Administrative 

Work Meeting will be closed to the 

public. 

Written Statements 

Pursuant to 41 CFR 102–3.105(j) and 

102–3.140, the public or interested 

organizations may submit written 

statements to the membership of the 

Panel at any time or in response to the 

stated agenda of a planned meeting. 

Written statements should be submitted 

to the Panel’s Designated Federal 

Officer. The Designated Federal 

Officer’s contact information can be 

obtained from the General Services 

Administration’s Federal Advisory 

Committee Act Database—https:// 

www.fido.gov/facadatabase/public.asp. 

Written statements that do not pertain 

to the scheduled meeting of the Panel 


sroberts on DSKD5P82C1PROD with NOTICES